Global genomics project unravels cancer's complexity at unprecedented scale.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.Frontiers in immunology · 2021
   Trial
2. YAP1 induces hepatocellular carcinoma via DNA demethylation rather than by canonical driver gene mutations.Communications biology · 2026
   Article
3. Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy.MedComm · 2026
   Review
4. Advances in Making Cancer Mouse Models More Accessible and Informative through Non-Germline Genetic Engineering.Cold Spring Harbor perspectives in medicine · 2024
   Review
5. Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma.BMC bioinformatics · 2023
   Article
6. CpG Site-Based Signature Predicts Survival of Colorectal Cancer.Biomedicines · 2022
   Article
7. Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer.Cancers · 2022
   Article
8. Esophageal Cancer Genomics in Africa: Recommendations for Future Research.Frontiers in genetics · 2022
   Article
9. Recent Advances in Pediatric Cancer Research.Cancer research · 2021
   Review
10. Global mapping of cancers: The Cancer Genome Atlas and beyond.Molecular oncology · 2021
    Review
11. Non-coding driver mutations in human cancer.Nature reviews. Cancer · 2021
    Review
12. Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies.Cancers · 2021
    Review
13. Identifying key questions in the ecology and evolution of cancer.Evolutionary applications · 2021
    Article
14. The International Collaboration for Cancer Classification and Research.International journal of cancer · 2021
    Article
15. Comprehensive Analysis of FOXO1 as a Tumour Suppressor Biomarker Related to Immune Infiltration and Cell Proliferation of Hepatocellular Carcinoma.IET systems biology
    Article

Corrections and comments

• Commented on by
  The era of massive cancer sequencing projects has reached a turning point.2020
• Comment on
  Patterns of somatic structural variation in human cancer genomes.2020
• Comment on
  The evolutionary history of 2,658 cancers.2020
• Comment on
  Pan-cancer analysis of whole genomes.2020
• Comment on
  The repertoire of mutational signatures in human cancer.2020
• Comment on
  Genomic basis for RNA alterations in cancer.2020
• Comment on
  Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as